Tag: PD
UKKW 2024 audience agrees that PD is the optimal dialysis modality...
At the recent UK Kidney Week (UKKW) meeting (11–13 June, Edinburgh, UK), a debate was held on the topic of dialysis modalities and which...
Peritoneal dialysis patients should be alerted to drain pain risk, say...
In a research letter submitted to the editor of the American Journal of Kidney Diseases (AJKD), investigators including lead Zeenia Aga and corresponding author...
First enrolment in wearable peritoneal dialysis device trial
AWAK Technologies and Singapore General Hospital (SGH) have announced the launch of a pre-pivotal clinical trial with the enrolment of their first subject to...
Physicians hear global patient perspectives about life on dialysis
From insights on living with different treatment modalities, to problems created by poor physician-patient communication and long-term psychological challenges, kidney care physicians heard a...
UK Renal Registry annual report reveals uptick in peritoneal dialysis amidst...
James Medcalf (Leicester, UK), UK Renal Registry medical director, tells Renal Interventions at UK Kidney Week (UKKW 2022; 7–9 June, Birmingham, UK), “This year...
UKKW 2022: Study indicates peritoneal dialysis is a safe and effective...
Attendees at this year’s UK Kidney Week (UKKW; 7–9 June, Birmingham, UK) heard that—based on a recent, single-centre study—peritoneal dialysis (PD) appears to be...
UKKW 2022: Funder engagement and patient support essential to home dialysis...
Funder-provider engagement and patient education are vital in growing home dialysis uptake across an entire region or country. Financial incentives or performance targets are...
UK Renal Registry: Peritoneal dialysis climbs despite overall RRT decrease
With comprehensive UK Renal Registry (UKRR) data from 2020 set to be published by the UK Kidney Association (UKKA) imminently, Renal Interventions previews a...
Invizius awarded grant to research peritoneal dialysis indication for H-Guard technology
Invizius recently announced that it has been awarded a second Biomedical Catalyst grant (Feasibility and Primer Award) by Innovate UK to research a new...
Relavo awarded US$1 million to support PeritoneX disinfection system
Relavo has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant worth US$1 million, which will be used to complete...
Newer techniques for PD surgery: Time-due advance or tempest in a...
As dialysis modalities go, peritoneal dialysis (PD) is currently among the more popular choices in treating kidney disease patients. For many physicians, its perceived...
CloudCath receives FDA clearance for novel at-home monitoring system in peritoneal...
CloudCath announced today it has received US Food and Drug Administration (FDA) clearance for the CloudCath system—which the company claims is the world's first...
Improved understanding of current dialysis modalities may hold greater value than...
There are several different types of dialysis treatment available to kidney disease patients—with the three major players, in-centre haemodialysis (ICHD), home haemodialysis (HHD) and...